Literature DB >> 29704220

Therapeutic applications of CRISPR/Cas9 system in gene therapy.

Hasan Mollanoori1, Shahram Teimourian2,3.   

Abstract

Gene therapy is based on the principle of the genetic manipulation of DNA or RNA for treating and preventing human diseases. The clustered regularly interspaced short palindromic repeats/CRISPR associated nuclease9 (CRISPR/Cas9) system, derived from the acquired immune system in bacteria and archaea, has provided a new tool for accurate manipulation of genomic sequence to attain a therapeutic result. The advantage of CRISPR which made it an easy and flexible tool for diverse genome editing purposes is that a single protein (Cas9) complex with 2 short RNA sequences, function as a site-specific endonuclease. Recently, application of CRISPR/Cas9 system has become popular for therapeutic aims such as gene therapy. In this article, we review the fundamental mechanisms of CRISPR-Cas9 function and summarize preclinical CRISPR-mediated gene therapy reports on a wide variety of disorders.

Entities:  

Keywords:  CRISPR/cas9; Gene therapy

Mesh:

Year:  2018        PMID: 29704220     DOI: 10.1007/s10529-018-2555-y

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  13 in total

Review 1.  Enhancing the Therapeutic Potential of Mesenchymal Stem Cells with the CRISPR-Cas System.

Authors:  Daniel Mendes Filho; Patrícia de Carvalho Ribeiro; Lucas Felipe Oliveira; Ana Luiza Romero Terra Dos Santos; Ricardo Cambraia Parreira; Mauro Cunha Xavier Pinto; Rodrigo Ribeiro Resende
Journal:  Stem Cell Rev Rep       Date:  2019-08       Impact factor: 5.739

2.  CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa.

Authors:  Wen-Hsuan Wu; Yi-Ting Tsai; I-Wen Huang; Chia-Hua Cheng; Chun-Wei Hsu; Xuan Cui; Joseph Ryu; Peter M J Quinn; Salvatore Marco Caruso; Chyuang-Sheng Lin; Stephen H Tsang
Journal:  Mol Ther       Date:  2022-02-10       Impact factor: 12.910

3.  Heme oxygenase 1 facilitates cell proliferation via the B-Raf-ERK signaling pathway in melanoma.

Authors:  Liu Liu; Yan Wu; Chunxiang Bian; Muhammad Farrukh Nisar; Mei Wang; Xiangyu Hu; Qingchun Diao; Weiqi Nian; Enwen Wang; Wei Xu; Julia Li Zhong
Journal:  Cell Commun Signal       Date:  2019-01-11       Impact factor: 5.712

Review 4.  Advances in Sphingolipidoses: CRISPR-Cas9 Editing as an Option for Modelling and Therapy.

Authors:  Renato Santos; Olga Amaral
Journal:  Int J Mol Sci       Date:  2019-11-24       Impact factor: 5.923

5.  Construction of a rAAV-SaCas9 system expressing eGFP and its application to improve muscle mass.

Authors:  Shaoting Weng; Yitian Zhao; Changhong Yu; Xiaofan Wang; Xuehan Xiao; Liqiang Han; Kunpeng Zhang; Jiang Wang; Guoyu Yang
Journal:  Biotechnol Lett       Date:  2021-09-29       Impact factor: 2.461

Review 6.  Challenges of CRISPR-Based Gene Editing in Primary T Cells.

Authors:  Alaleh Rezalotfi; Lea Fritz; Reinhold Förster; Berislav Bošnjak
Journal:  Int J Mol Sci       Date:  2022-02-01       Impact factor: 5.923

Review 7.  Recombinant Human Adenovirus-p53 Therapy for the Treatment of Oral Leukoplakia and Oral Squamous Cell Carcinoma: A Systematic Review.

Authors:  Jagadish Hosmani; Shazia Mushtaq; Shahabe Saquib Abullais; Hussain Mohammed Almubarak; Khalil Assiri; Luca Testarelli; Alessandro Mazzoni; Shankargouda Patil
Journal:  Medicina (Kaunas)       Date:  2021-05-01       Impact factor: 2.430

8.  Abrogation of PRRSV infectivity by CRISPR-Cas13b-mediated viral RNA cleavage in mammalian cells.

Authors:  Jin Cui; Navapon Techakriengkrai; Teerawut Nedumpun; Sanipa Suradhat
Journal:  Sci Rep       Date:  2020-06-15       Impact factor: 4.379

9.  Human Organic Anion Transporting Polypeptide 1B3 Applied as an MRI-Based Reporter Gene.

Authors:  Song Ee Baek; Asad Ul-Haq; Dae Hee Kim; Hyoung Wook Choi; Myeong Jin Kim; Hye Jin Choi; Honsoul Kim
Journal:  Korean J Radiol       Date:  2020-06       Impact factor: 3.500

Review 10.  CRISPR: a journey of gene-editing based medicine.

Authors:  Zhabiz Golkar
Journal:  Genes Genomics       Date:  2020-10-22       Impact factor: 1.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.